298 related articles for article (PubMed ID: 16439696)
21. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
[TBL] [Abstract][Full Text] [Related]
22. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol.
Ribo M; Molina CA; Rovira A; Quintana M; Delgado P; Montaner J; Grivé E; Arenillas JF; Alvarez-Sabín J
Stroke; 2005 Mar; 36(3):602-6. PubMed ID: 15692107
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
[TBL] [Abstract][Full Text] [Related]
25. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
[TBL] [Abstract][Full Text] [Related]
26. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.
Liao X; Wang Y; Pan Y; Wang C; Zhao X; Wang DZ; Wang C; Liu L; Wang Y;
Stroke; 2014 Aug; 45(8):2354-8. PubMed ID: 25013020
[TBL] [Abstract][Full Text] [Related]
27. Reperfusion therapy in unclear-onset stroke based on MRI evaluation (RESTORE): a prospective multicenter study.
Kang DW; Sohn SI; Hong KS; Yu KH; Hwang YH; Han MK; Lee J; Park JM; Cho AH; Kim HJ; Kim DE; Cho YJ; Koo J; Yun SC; Kwon SU; Bae HJ; Kim JS
Stroke; 2012 Dec; 43(12):3278-83. PubMed ID: 23093613
[TBL] [Abstract][Full Text] [Related]
28. Stroke lesion volumes and outcome are not different in hemispheric stroke side treated with intravenous thrombolysis based on magnetic resonance imaging criteria.
Golsari A; Cheng B; Sobesky J; Schellinger PD; Fiehler J; Gerloff C; Thomalla G
Stroke; 2015 Apr; 46(4):1004-8. PubMed ID: 25700285
[TBL] [Abstract][Full Text] [Related]
29. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
30. Does the Primary Imaging Modality-Computed Tomography or Magnetic Resonance Imaging-Influence Stroke Physicians' Certainty on Whether or Not to Give Thrombolysis to Randomized Acute Stroke Patients?
Hansen CK; Christensen A; Rodgers H; Havsteen I; Kruuse C; Christensen H
J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):926-935. PubMed ID: 29198901
[TBL] [Abstract][Full Text] [Related]
31. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
[TBL] [Abstract][Full Text] [Related]
32. Safety of intravenous thrombolytic use in four emergency departments without acute stroke teams.
Scott PA; Frederiksen SM; Kalbfleisch JD; Xu Z; Meurer WJ; Caveney AF; Sandretto A; Holden AB; Haan MN; Hoeffner EG; Ansari SA; Lambert DP; Jaggi M; Barsan WG; Silbergleit R
Acad Emerg Med; 2010 Oct; 17(10):1062-71. PubMed ID: 21040107
[TBL] [Abstract][Full Text] [Related]
33. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
[TBL] [Abstract][Full Text] [Related]
34. Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial.
Daffertshofer M; Gass A; Ringleb P; Sitzer M; Sliwka U; Els T; Sedlaczek O; Koroshetz WJ; Hennerici MG
Stroke; 2005 Jul; 36(7):1441-6. PubMed ID: 15947262
[TBL] [Abstract][Full Text] [Related]
35. Ischemic stroke subtype is associated with outcome in thrombolyzed patients.
Schmitz ML; Simonsen CZ; Svendsen ML; Larsson H; Madsen MH; Mikkelsen IK; Fisher M; Johnsen SP; Andersen G
Acta Neurol Scand; 2017 Feb; 135(2):176-182. PubMed ID: 26991747
[TBL] [Abstract][Full Text] [Related]
36. Treating ischaemic stroke with intravenous tPA beyond 4.5 hours under the guidance of a MRI DWI/T2WI mismatch was safe and effective.
Bai QK; Zhao ZG; Lu LJ; Shen J; Zhang JY; Sui HJ; Xie XH; Chen J; Yang J; Chen CR
Stroke Vasc Neurol; 2019 Mar; 4(1):8-13. PubMed ID: 31105973
[TBL] [Abstract][Full Text] [Related]
37. Outcome of multimodal MRI-guided intravenous thrombolysis in patients with stroke with unknown time of onset.
Zhao J; Zhao H; Li R; Li J; Liu C; Lv J; Li Y; Liu W; Ma D; Hao H; Xiao X; Liu J; Yin Y; Liu R; Yu Q; Wei Y; Li P; Wang Y; Wang R
Stroke Vasc Neurol; 2019 Mar; 4(1):3-7. PubMed ID: 31105972
[TBL] [Abstract][Full Text] [Related]
38. Intravenous thrombolysis for patients with reverse magnetic resonance angiography and diffusion-weighted imaging mismatch: SAMURAI and NCVC rt-PA Registries.
Sakamoto Y; Koga M; Kimura K; Nagatsuka K; Okuda S; Kario K; Hasegawa Y; Okada Y; Yamagami H; Furui E; Nakagawara J; Shiokawa Y; Okata T; Kobayashi J; Tanaka E; Minematsu K; Toyoda K
Eur J Neurol; 2014 Mar; 21(3):419-26. PubMed ID: 24261412
[TBL] [Abstract][Full Text] [Related]
39. Thrombolysis in ischemic stroke without arterial occlusion at presentation.
Lahoti S; Gokhale S; Caplan L; Michel P; Samson Y; Rosso C; Limaye K; Hinduja A; Singhal A; Ali S; Pettigrew LC; Kryscio R; Dedhia N; Hastak S; Liebeskind DS
Stroke; 2014 Sep; 45(9):2722-7. PubMed ID: 25074517
[TBL] [Abstract][Full Text] [Related]
40. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
